BKNG vs KNSA · P/E 36, rev $7.35B vs P/E 53, rev $677.6M
Booking Holdings Inc (BKNG) versus Kiniksa Pharmaceuticals Ltd (KNSA) — a side-by-side from cached financials, not a winner call.
Booking Holdings Inc (BKNG) is a travel services company listed on US. It is led by Glenn D. Fogel.
Kiniksa Pharmaceuticals Ltd (KNSA) is a drug manufacturers - specialty & generic company listed on US.
Latest reported BKNG revenue for 2026-06-30 was $7.35B. Revenue was up 32.9% from 2026-03-31 to 2026-06-30. BKNG currently screens at market cap $186.03B and trailing P/E 35.6.
Latest reported KNSA revenue for 2025-12-31 was $677.6M. Net income was $59.0M. Revenue was up 60.1% from 2024-12-31 to 2025-12-31. KNSA currently screens at market cap $3.73B and trailing P/E 53.2.
BKNG currently screens at market cap $186.03B and trailing P/E 35.6. KNSA currently screens at market cap $3.73B and trailing P/E 53.2.
Not investment advice. Open the BKNG and KNSA stock pages for the full models.
Not investment advice.